FATE THERAPEUTICS INC
FATE·31189P102·US·Common Stock·Healthcare - Biotechnology-Activist
FATE (FATE THERAPEUTICS INC) is held by 82 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($19.7M), VANGUARD PORTFOLIO MANAGEMENT LLC ($12.3M), VANGUARD CAPITAL MANAGEMENT LLC ($12M). Net institutional sentiment: Mixed.
82
Holders
(6 Elite)
$123.7M
Total Value
54% (96)
Consensus
52 buying - 44 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 12, 2026 · Insiders Aug 5, 2026 · Activists Jul 8, 2026 · Congress none
InsiderTCTAHL CINDYSell $95KAug 4, 2026
InsiderVBValamehr BahramSell $108KAug 4, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 102
1 / 6
Continue exploring
Other Healthcare stocks held by institutions
417 holders · $300.5B
416 holders · $881.6B
401 holders · $151.5B
398 holders · $415.6B
395 holders · $98.9B
394 holders · $111.8B
391 holders · $230.3B
386 holders · $303.9B
386 holders · $52.4B
383 holders · $114.2B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer